Bullish option flow detected in Recursion Pharmaceuticals with 3,443 calls trading, 1.2x expected, and implied vol increasing over 3 points to 73.01%. Oct-24 8 calls and Mar-25 10 calls are the most active options, with total volume in those strikes near 1,200 contracts. The Put/Call Ratio is 0.24. Earnings are expected on November 7th.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Cathie Wood’s ARK Investment bought 457K shares of Recursion Pharmaceuticals
- Small Cap Stocks: Recursion Pharmaceuticals (RXRX) Applying AI and Strategic Partnerships
- Cathie Wood’s ARK Investment bought 156K shares of Recursion Pharmaceuticals
- Cathie Wood’s ARK Investment bought 139K shares of Recursion Pharmaceuticals
- CORRECTION – Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results